Indie Semiconductor, Inc. current report, 12 October 2021

Full document

Indie Semiconductor, Inc. Form 8-K Summary

Business Context and Reporting Period

Indie Semiconductor, Inc. reported the completion of its acquisition of all outstanding capital stock of TeraXion Inc., a Canadian corporation, on October 12, 2021. The transaction was completed under an August 27, 2021 Share Purchase Agreement. The report was signed on October 15, 2021.

Transaction Consideration and Capitalization

  • Cash consideration was approximately $80 million.
  • Indie issued 5,805,144 shares of Class A common stock to former TeraXion stockholders.
  • Indie assumed TeraXion options exercisable for 1,542,332 shares of Indie Class A common stock.
  • The shares were issued under the private-placement exemption in Section 4(a)(2) of the Securities Act or Rule 506.

Material Changes Versus the Prior Comparable Period

This filing reports a corporate acquisition and related equity issuance rather than periodic operating results. The filing text does not provide revenue, profit, cash flow, margin, debt, liquidity, or other comparable-period financial metrics.

Guidance, Outlook, Risks, and Unusual Items

  • Indie agreed to file a Form S-1 registration statement to register the resale of the shares issued to TeraXion stockholders.
  • Indie agreed to file a Form S-8 registration statement for shares issuable upon exercise of the assumed TeraXion options.
  • The transaction creates potential dilution from both the 5,805,144 shares issued at closing and the 1,542,332 shares subject to assumed options.
  • The filing provides no operating guidance, outlook, management commentary, contingencies, or detailed acquisition accounting information.

Important Facts for Investors to Verify

  1. Completion and final terms of the TeraXion acquisition.
  2. Funding source and balance-sheet impact of the approximately $80 million cash payment.
  3. Actual dilution from the shares issued and assumed options.
  4. Filing and effectiveness of the planned Form S-1 and Form S-8 registration statements.
  5. Subsequent filings describing TeraXion’s contribution to revenue, expenses, cash flow, and operating results.